CheckMate 067: A phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with ipilimumab (IPI) versus IPI monotherapy in previously untreated patients (pts) with advanced melanoma (MEL) Meeting Abstract
| Authors: | Wolchok, J. D.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J.; Cowey, C. L.; Lao, C. D.; Schadendorf, D.; Ferrucci, P. F.; Smylie, M.; Dummer, R.; Hill, A.; Haanen, J.; Maio, M.; McArthur, G.; Yang, A.; Rollin, L.; Horak, C.; Larkin, J.; Hodi, F. S. |
| Abstract Title: | CheckMate 067: A phase III randomized double-blind study of nivolumab (NIVO) monotherapy or NIVO combined with ipilimumab (IPI) versus IPI monotherapy in previously untreated patients (pts) with advanced melanoma (MEL) |
| Meeting Title: | 17th National Congress of Medical Oncology |
| Journal Title: | Annals of Oncology |
| Volume: | 26 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2015 Oct 23-25 |
| Meeting Location: | Rome, Italy |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2015-10-01 |
| Start Page: | vi28 |
| Language: | English |
| ACCESSION: | WOS:000365159600089 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdv337.08 |
| Notes: | Meeting Abstract: B08 -- Source: Wos |
